Scholar Rock Holding Corporation

Scholar Rock Holding Corporation

45.08
USD
+0.54
(+1.21%)
-3.35EPS
5.89BMarket Cap
Mar 09Next Earn

Scholar Rock Holding Corporation Documents

Q1 FY2021 · Press release

Scholar Rock Announces Positive 12-Month Top-Line Results From the TOPAZ Phase 2 Clinical Trial Evaluating Apitegromab in Patients With Type 2 and Type 3 Spinal Muscular Atrophy (SMA) · April 6, 2021 · 4 pages

Read Scholar Rock Holding Corporation's results firsthand

Preview the first 2 pages of this press release
Create a free account to start reading

Full documents are included with Professional

Q1 FY2021 documents